The
facility offers a complete service from DNA preparation to screening of the
newly genetically engineered mice. The term ‘knockout’ is used here but the Core has just as often made ‘knock-in’
mice for our investigators and is experienced in the techniques of Cre/loxP
conditional knockout mouse construction, including the desire to sometimes
perform ‘secondary’ targeting events or transient Cre recombinase expression
in homologous recombinant ES cell clones. Most of our investigators design and construct their own
targeting constructs, but for those who do not we can highly recommend
trusted partners that can perform all DNA design and construction steps at
relatively low cost. Services
offered by the Core include design and execution of PCR-based screening
strategies, ES cell and mouse tail DNA preparation, ES cell gene targeting by
homologous recombination, ES cell injection into blastocysts and chimeric
mouse breeding. Knockout mice
are produced on a C57BL/6 background using our exclusive, published C57BL/6
LK1 embryonic stem (ES) cells. Thus, knockout mice are produced on a C57BL/6 background, which is
often the mouse background of choice for our investigators’ basic
research. Investigators are
encouraged to submit a preliminary application
form with the planned targeting before proceeding with targeting
construct preparation. Investigators are also encouraged to adhere to the DNA preparation guide. Through this service, the core will generate chimeric mice
by injecting ES cells containing site-specific genomic alterations
(knockouts, knock-ins, etc) into normal blastocysts. ES cells will be injected into a
minimum of 100 blastocysts per homologous recombinant clone, and for up to 3
such clones if available. The
blastocysts will be transferred into the uterine horn of a 3-day
pseudopregnant female and allowed to go to term (17 days after embryo
transfer).
Due
to the fact that this approach is time-consuming, it is recommended that
certain guidelines be followed in order to minimize loss of time and reduce
risk factors. These guidelines include:
